Skip to content
Isomorphic Labs logo

Isomorphic Labs in the Media

15 mentions across press, blogs, and newsletters

Top coverageForbesBloombergSifted
2 major ·1 tech media

May 2026

TechFundingNews

Isomorphic Labs is British AI darling, but the cap table tells a different story

AI drug discovery company Isomorphic Labs, a Google D

May 18, 2026
ForbesMajor Publication

Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery

Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic.

May 13, 2026
TechFundingNews

DeepMind spinout Isomorphic Labs closes $2.1B from Thrive Capital, GV, Alphabet for AI drug discovery

Isomorphic Labs has landed a massive $2.1 billion Ser

May 13, 2026
SiliconRepublic

Alphabet’s Isomorphic Labs raises $2.1bn in Series B funding

The organisation plans to use the investment as a means of accelerating the application of its AI model, at scale. Read more: Alphabet’s Isomorphic L

May 13, 2026
The Decoder

Alphabet's Isomorphic Labs raises $2.1 billion to scale AI drug discovery toward clinical trials

Isomorphic Labs, the AI drug research company led by DeepMind co-founder De

May 12, 2026
Quartz

Alphabet's Isomorphic Labs raised $2.1 billion to push AI-designed drugs toward clinical trials

The Alphabet spinout plans to use the capital to expand its drug pipeline and push candidates toward clinical trials by the end of 2026

May 12, 2026
Techstartups

Alphabet-backed Isomorphic Labs raises $2.1B to accelerate AI-designed drug discovery as clinical trials near

Drug discovery has long been one of the slowest and most expensive parts of modern medicine. Isomorphic Labs, a drug discovery startup spun out of Google DeepMind, wants artificial intelligence to change that, and investors are betting billions that it can. [&#8230;] The post <a href="http

May 12, 2026
SiftedTech Media

DeepMind spinout Isomorphic Labs raises $2.1bn

DeepMind spinout Isomorphic Labs, which is working on AI-designed drugs, has raised $2.1bn led by US venture firm Thrive Capital.

May 12, 2026
TechFundingNews

DeepMind spinout Isomorphic Labs eyes over $2B funding from Thrive and Alphabet

London-based Isomorphic Labs, the drug discovery star

May 11, 2026
EconomicTimes - IndiaTimes

Google’s Isomorphic Labs to raise over $2 billion in new funding

Alphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. This significant investment aims to bolster its drug design engine and fuel global expansion, underscoring Alphabet's strategy of commercializing its advanced AI

May 9, 2026
SiliconAngle

Alphabet’s Isomorphic Labs reportedly raising $2B+ for its medical research AI

Isomorphic Labs Inc., an Alphabet Inc. unit using artificial intelligence to speed up drug development, is reportedly in talks to raise a new funding round. Sources told Bloomberg today that the investment could be worth more than $2 billion. OpenAI Group PBC backer Thrive Capital, an existing Is

May 9, 2026
BloombergMajor Publication

Google’s Isomorphic Labs to Raise Over $2 Billion in New Funding

Isomorphic Labs, an AI-powered drug discovery company spun out of Alphabet Inc.’s Google DeepMind, is in advanced discussions to raise more than $2 billion in a new round of funding, according to people familiar with the plan.

May 8, 2026

February 2026

Toolradar Research

See Isomorphic Labs in context: The SaaS Press Index 2026

We analyzed 6,704 press mentions across 290 outlets to rank which SaaS tools win coverage. Find Isomorphic Labs's position relative to the 488 most-covered tools.

Read the report

Explore Isomorphic Labs

Press coverage is one signal. See the full picture.